SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-025679
Filing Date
2023-07-27
Accepted
2023-07-27 16:05:19
Documents
12
Period of Report
2023-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 36728
  Complete submission text file 0001493152-23-025679.txt   209873

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vbiv-20230623.xsd EX-101.SCH 3024
3 XBRL LABEL FILE vbiv-20230623_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE vbiv-20230623_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3363
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37769 | Film No.: 231118390
SIC: 2834 Pharmaceutical Preparations